EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors

Area of Science:

• Genomics
• Cancer Biology
• Molecular Oncology

Background:

• Microsatellite instability (MSI) involves genomic alterations due to DNA mismatch repair defects, impacting cancer prognosis and treatment.
• Elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) is a recently identified phenomenon associated with inflammation, advanced tumor stage, and poor outcomes.
• The precise relationship between EMAST and MSI, including its potential origins and clinical implications, remains largely undefined.

Purpose of the Study:

• To clarify the clinical significance of EMAST in tumors.
• To investigate the relationship between EMAST and MSI.
• To determine if EMAST represents a distinct genomic instability mechanism or a secondary event.

Main Methods:

• Analysis of genomic alterations in tumor samples.
• Comparison of EMAST and MSI profiles across various cancer types.
• Correlation of EMAST status with clinical parameters and patient prognosis.

Main Results:

• EMAST has been observed in diverse tumor types, often linked to chronic inflammation and adverse prognostic factors.
• Previous associations suggested EMAST with MSI-low tumors, but recent findings indicate overlap with MSI-high phenotypes.
• The occurrence of microsatellite frameshifts in microsatellite-stable (MSS) tumors complicates the definition of EMAST as a unique instability type.

Conclusions:

• The exact role of EMAST in cancer progression and its distinction from MSI warrant further research.
• EMAST may influence immunotherapy response in MSI tumors, suggesting a potential modifying role.
• Understanding EMAST is crucial for refining cancer diagnosis, prognosis, and therapeutic strategies.